Coreceptor usage by HIV-1 and HIV-2 primary isolates: The relevance of CCR8 chemokine receptor as an alternative coreceptor

被引:29
|
作者
Calado, M. [1 ]
Matoso, P. [1 ]
Santos-Costa, Q. [1 ]
Espirito-Santo, M. [1 ]
Machado, J. [2 ]
Rosado, L. [3 ]
Antunes, F.
Mansinho, K. [4 ]
Lopes, M. M. [1 ]
Maltez, F. [2 ]
Santos-Ferreira, M. O. [1 ]
Azevedo-Pereira, J. M. [1 ]
机构
[1] Univ Lisbon, Ctr Patogenese Mol, Unidade Retrovirus & Infeccoes Associadas, Fac Farm, P-1649003 Lisbon, Portugal
[2] Hosp Curry Cabral, Serv Doencas Infecciosas, Lisbon, Portugal
[3] Hosp Dona Estefania, Serv Infecciol, Lisbon, Portugal
[4] Hosp Egas Moniz, Unidade Doencas Infecciosas & Parasitarias, Lisbon, Portugal
关键词
HIV-1; HIV-2; HIV coreceptor; CCR8; Chemokine receptor; Primary isolate; Pathogenesis; Cellular receptor; Entry inhibitor; Antiretroviral therapy; HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; IN-VIVO; DISEASE PROGRESSION; CXCR4; CORECEPTORS; MOLECULAR-CLONING; TYPE-1; INFECTION; MULTIPLE CORECEPTORS; HUMAN THYMOCYTES; DIVERSE HUMAN;
D O I
10.1016/j.virol.2010.09.020
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus replication cycle begins by sequential interactions between viral envelope glycoproteins with CD4 molecule and a member of the seven-transmembrane. G-protein-coupled, receptors' family (coreceptor). In this report we focused on the contribution of CCR8 as alternative coreceptor for HIV-1 and HIV-2 isolates. We found that this coreceptor was efficiently used not only by HIV-2 but particularly by HIV-1 isolates. We demonstrate that CXCR4 usage, either alone or together with CCR5 and/or CCR8, was more frequently observed in HIV-1 than in HIV-2 isolates. Directly related to this is the finding that the non-usage of CXCR4 is significantly more common in HIV-2 isolates; both features could be associated with the slower disease progression generally observed in HIV-2 infected patients. The ability of some viral isolates to use alternative coreceptors besides CCR5 and CXCR4 could further impact on the efficacy of entry inhibitor therapy and possibly also in HIV pathogenesis. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 50 条
  • [21] Phenotytic Knockout of HIV-1 Chemokine Coreceptor CXCR4 and CCR5 by Intrakines for Blocking HIV-1 Infection
    张颖
    张岩
    王平忠
    王九平
    黄长形
    孙永涛
    白雪帆
    JournalofMicrobiologyandImmunology, 2004, (04) : 255 - 259
  • [22] Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity
    Blanpain, C
    Lee, B
    Vakili, J
    Doranz, BJ
    Govaerts, C
    Migeotte, I
    Sharron, M
    Dupriez, V
    Vassart, G
    Doms, RW
    Parmentier, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 18902 - 18908
  • [23] Extracellular cysteines of CCR5 are required for chemokine binding, but, dispensable for HIV-1 coreceptor activity
    Blanpain, Cedric
    Lee, Benhur
    Vakili, Jalal
    Doranz, Benjamin J.
    Govaerts, Cedric
    Migeotte, Isabelle
    Sharron, Matthew
    Dupriez, Vincent
    Vassart, Gilbert
    Doms, Robert W.
    Parmentier, Marc
    Journal of Biological Chemistry, 274 (27): : 18902 - 18908
  • [24] HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism
    Zhang, LQ
    Carruthers, CD
    He, T
    Huang, YX
    Cao, YZ
    Wang, G
    Hahn, B
    Ho, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (16) : 1357 - 1366
  • [25] The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates
    Lin, Nina H.
    Negusse, Daniel M.
    Beroukhim, Rameen
    Giguel, Francoise
    Lockman, Shahin
    Essex, Myron
    Kuritzkes, Daniel R.
    JOURNAL OF VIROLOGICAL METHODS, 2010, 169 (01) : 39 - 46
  • [26] Using Ultradeep Pyrosequencing to Study HIV-1 Coreceptor Usage in Primary and Dual Infection
    Wagner, Gabriel A.
    Pacold, Mary E.
    Vigil, Edgar
    Caballero, Gemma
    Morris, Sheldon R.
    Pond, Sergei L. Kosakovsky
    Little, Susan J.
    Richman, Douglas D.
    Gianella, Sara
    Smith, Davey M.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (02): : 271 - 274
  • [27] Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection
    Yang, AG
    Bai, XF
    Huang, XF
    Yao, CP
    Chen, SY
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) : 11567 - 11572
  • [28] Analysis of Physicochemical and Structural Properties Determining HIV-1 Coreceptor Usage
    Bozek, Katarzyna
    Lengauer, Thomas
    Sierra, Saleta
    Kaiser, Rolf
    Domingues, Francisco S.
    PLOS COMPUTATIONAL BIOLOGY, 2013, 9 (03)
  • [29] Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1
    Zhang, LQ
    He, T
    Huang, YX
    Chen, ZW
    Guo, Y
    Wu, S
    Kunstman, KJ
    Brown, RC
    Phair, JP
    Neumann, AU
    Ho, DD
    Wolinsky, SM
    JOURNAL OF VIROLOGY, 1998, 72 (11) : 9307 - 9312
  • [30] The rhesus macaque CCR3 chemokine receptor is a cell entry cofactor for HIV-2, but not for HIV-1
    Sol, N
    Tréboute, C
    Gomas, E
    Ferchal, F
    Shacklett, B
    Alizon, M
    VIROLOGY, 1998, 240 (02) : 213 - 220